AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 50.01 USD -0.06% Market Closed
Market Cap: 1.4B USD

Wall Street
Price Targets

ANAB Price Targets Summary
AnaptysBio Inc

Wall Street analysts forecast ANAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANAB is 58.14 USD with a low forecast of 20.2 USD and a high forecast of 105 USD.

Lowest
Price Target
20.2 USD
60% Downside
Average
Price Target
58.14 USD
16% Upside
Highest
Price Target
105 USD
110% Upside
AnaptysBio Inc Competitors:
Price Targets
300676
BGI Genomics Co Ltd
30% Upside
PHARM
Pharming Group NV
45% Upside
PGEN
Precigen Inc
107% Upside
BIOCON
Biocon Ltd
11% Upside
NTRA
Natera Inc
4% Upside
ZEAL
Zealand Pharma A/S
57% Upside
IMDX
Insight Molecular Diagnostics Inc
23% Upside
CRVO
Diffusion Pharmaceuticals Inc
170% Upside

Revenue
Forecast

Revenue Estimate
AnaptysBio Inc

For the last 10 years the compound annual growth rate for AnaptysBio Inc's revenue is 19%. The projected CAGR for the next 4 years is 34%.

19%
Past Growth
34%
Estimated Growth
Estimates Accuracy
12%
Average Beat

Operating Income
Forecast

Operating Income Estimate
AnaptysBio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
AnaptysBio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANAB's stock price target?
Price Target
58.14 USD

According to Wall Street analysts, the average 1-year price target for ANAB is 58.14 USD with a low forecast of 20.2 USD and a high forecast of 105 USD.

What is AnaptysBio Inc's Revenue forecast?
Projected CAGR
34%

For the last 10 years the compound annual growth rate for AnaptysBio Inc's revenue is 19%. The projected CAGR for the next 4 years is 34%.

Back to Top